Victory Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $638K | Buy |
45,616
+3,989
| +10% | +$55.8K | ﹤0.01% | 2006 |
|
2025
Q1 | $566K | Buy |
41,627
+3,119
| +8% | +$42.4K | ﹤0.01% | 1996 |
|
2024
Q4 | $785K | Sell |
38,508
-1,392
| -3% | -$28.4K | ﹤0.01% | 1905 |
|
2024
Q3 | $1.16M | Buy |
39,900
+24,767
| +164% | +$721K | ﹤0.01% | 1721 |
|
2024
Q2 | $351K | Buy |
15,133
+390
| +3% | +$9.06K | ﹤0.01% | 2064 |
|
2024
Q1 | $303K | Sell |
14,743
-605
| -4% | -$12.4K | ﹤0.01% | 2120 |
|
2023
Q4 | $329K | Buy |
15,348
+3,267
| +27% | +$70.1K | ﹤0.01% | 2100 |
|
2023
Q3 | $249K | Buy |
12,081
+630
| +6% | +$13K | ﹤0.01% | 2163 |
|
2023
Q2 | $338K | Sell |
11,451
-267
| -2% | -$7.88K | ﹤0.01% | 2088 |
|
2023
Q1 | $270K | Sell |
11,718
-1,538
| -12% | -$35.4K | ﹤0.01% | 2172 |
|
2022
Q4 | $369K | Buy |
13,256
+1,631
| +14% | +$45.4K | ﹤0.01% | 2112 |
|
2022
Q3 | $357K | Buy |
11,625
+742
| +7% | +$22.8K | ﹤0.01% | 2186 |
|
2022
Q2 | $320K | Hold |
10,883
| – | – | ﹤0.01% | 2214 |
|
2022
Q1 | $259K | Sell |
10,883
-1,198
| -10% | -$28.5K | ﹤0.01% | 2345 |
|
2021
Q4 | $539K | Sell |
12,081
-9,627
| -44% | -$430K | ﹤0.01% | 2111 |
|
2021
Q3 | $1.1M | Sell |
21,708
-20,413
| -48% | -$1.03M | ﹤0.01% | 1820 |
|
2021
Q2 | $3.3M | Buy |
42,121
+3,766
| +10% | +$295K | ﹤0.01% | 1482 |
|
2021
Q1 | $2.19M | Buy |
38,355
+19,788
| +107% | +$1.13M | ﹤0.01% | 1627 |
|
2020
Q4 | $1.56M | Buy |
18,567
+6,099
| +49% | +$511K | ﹤0.01% | 1596 |
|
2020
Q3 | $447K | Sell |
12,468
-671
| -5% | -$24.1K | ﹤0.01% | 2004 |
|
2020
Q2 | $318K | Sell |
13,139
-14,107
| -52% | -$341K | ﹤0.01% | 2158 |
|
2020
Q1 | $478K | Buy |
27,246
+13,659
| +101% | +$240K | ﹤0.01% | 2108 |
|
2019
Q4 | $237K | Sell |
13,587
-1,848
| -12% | -$32.2K | ﹤0.01% | 2269 |
|
2019
Q3 | $236K | Buy |
+15,435
| New | +$236K | ﹤0.01% | 2164 |
|